{"id":"https://openalex.org/W2005918477","doi":"https://doi.org/10.1002/phar.1442","title":"Comparison of the Incidence of Vancomycin\u2010Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin\u2010Tazobactam","display_name":"Comparison of the Incidence of Vancomycin\u2010Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin\u2010Tazobactam","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-22","ids":{"openalex":"https://openalex.org/W2005918477","doi":"https://doi.org/10.1002/phar.1442","mag":"2005918477","pmid":"https://pubmed.ncbi.nlm.nih.gov/24855041"},"language":"en","primary_location":{"id":"doi:10.1002/phar.1442","doi":"https://doi.org/10.1002/phar.1442","is_oa":true,"landing_page_url":"https://doi.org/10.1002/phar.1442","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/phar.1442","source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005918477"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/phar.1442","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040088856","display_name":"Lindsey D. Burgess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210153043","display_name":"Duke University Hospital","ror":"https://ror.org/04bct7p84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4210153043"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey D. Burgess","raw_affiliation_strings":["Department of Pharmacy, Duke University Hospital, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Duke University Hospital, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4210153043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102958355","display_name":"Richard H. Drew","orcid":"https://orcid.org/0000-0003-0406-0804","observed_orcids":["https://orcid.org/0000-0003-0406-0804"]},"institutions":[{"id":"https://openalex.org/I132446568","display_name":"Campbell University","ror":"https://ror.org/00dv9q566","country_code":"US","type":"education","lineage":["https://openalex.org/I132446568"]},{"id":"https://openalex.org/I4210153043","display_name":"Duke University Hospital","ror":"https://ror.org/04bct7p84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4210153043"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard H. Drew","raw_affiliation_strings":["Campbell University College of Pharmacy and Health Sciences; Buies Creek North Carolina","Division of Infectious Diseases Duke University Hospital Durham North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Campbell University College of Pharmacy and Health Sciences; Buies Creek North Carolina","institution_ids":["https://openalex.org/I132446568"]},{"raw_affiliation_string":"Division of Infectious Diseases Duke University Hospital Durham North Carolina","institution_ids":["https://openalex.org/I4210153043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5102958355"],"corresponding_institution_ids":["https://openalex.org/I132446568","https://openalex.org/I4210153043"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":14.6243,"has_fulltext":true,"cited_by_count":216,"citation_normalized_percentile":{"value":0.9966835,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"34","issue":"7","first_page":"670","last_page":"676"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.459199994802475,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vancomycin-nephrotoxicity","display_name":"vancomycin nephrotoxicity","score":0.9739999771118164},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7440000176429749},{"id":"https://openalex.org/keywords/creatinine-elevation","display_name":"creatinine elevation","score":0.7009999752044678},{"id":"https://openalex.org/keywords/vancomycin-trough-concentration","display_name":"vancomycin trough concentration","score":0.949999988079071},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.8790000081062317},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/renal-function-monitoring","display_name":"renal function monitoring","score":0.5849999785423279},{"id":"https://openalex.org/keywords/confounding-factors","display_name":"confounding factors","score":0.42500001192092896},{"id":"https://openalex.org/keywords/charlson-comorbidity-index","display_name":"Charlson Comorbidity Index","score":0.8790000081062317},{"id":"https://openalex.org/keywords/old-age","display_name":"old age","score":0.6899999976158142},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8751351833343506},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.8375424146652222},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.836275577545166},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.7717816829681396},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.6386644840240479},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.6138402819633484},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.44426220655441284},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4438099265098572},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.44183576107025146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4317830801010132},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33896249532699585},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.10761567950248718},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.048784106969833374},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077725","descriptor_name":"Piperacillin, Tazobactam Drug Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058186","descriptor_name":"Acute Kidney Injury","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D058186","descriptor_name":"Acute Kidney Injury","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D058186","descriptor_name":"Acute Kidney Injury","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/phar.1442","doi":"https://doi.org/10.1002/phar.1442","is_oa":true,"landing_page_url":"https://doi.org/10.1002/phar.1442","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/phar.1442","source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:24855041","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24855041","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1002/phar.1442","doi":"https://doi.org/10.1002/phar.1442","is_oa":true,"landing_page_url":"https://doi.org/10.1002/phar.1442","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/phar.1442","source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005918477.pdf","grobid_xml":"https://content.openalex.org/works/W2005918477.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W572529599","https://openalex.org/W1422008199","https://openalex.org/W1989319949","https://openalex.org/W1990988313","https://openalex.org/W2011312924","https://openalex.org/W2042841791","https://openalex.org/W2056026648","https://openalex.org/W2059267457","https://openalex.org/W2080433928","https://openalex.org/W2116736766","https://openalex.org/W2126520713","https://openalex.org/W2127201283","https://openalex.org/W2138745304","https://openalex.org/W2139937737","https://openalex.org/W2149687213","https://openalex.org/W2152771638","https://openalex.org/W2315892587","https://openalex.org/W4238199262"],"related_works":["https://openalex.org/W2527052900","https://openalex.org/W2544684777","https://openalex.org/W2751192795","https://openalex.org/W2940907209","https://openalex.org/W2776815946","https://openalex.org/W7166528880","https://openalex.org/W4406952149","https://openalex.org/W2796817276","https://openalex.org/W2794250316","https://openalex.org/W4294217078"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVES:":[1],"To":[2],"determine":[3],"whether":[4],"the":[5,29,78,104,128,131,136,141,184,187,214,225,233,258,316],"addition":[6],"of":[7,14,31,67,70,87,90,103,106,130,138,145,157,172,186,191,210,221,240,254,271,277,289,303,315,318],"piperacillin-tazobactam":[8,92,97,114,263],"leads":[9],"to":[10,21,126,182,265],"an":[11,251,268,274,286,312],"increased":[12,252,269,287,313],"incidence":[13,137,185,270,288],"nephrotoxicity":[15,139,290],"in":[16,77,199,207,213,218,224,291,325],"patients":[17,212,223,261,293],"receiving":[18],"vancomycin":[19,71,107,112,146,154,170,215,237,266,300],"and":[20,54,166,217],"explore":[22],"potential":[23],"confounding":[24],"factors":[25,134],"that":[26],"may":[27],"increase":[28,198],"risk":[30,133,253,314],"vancomycin-induced":[32],"nephrotoxicity.":[33,256,319],"DESIGN:":[34],"Single-center,":[35],"retrospective":[36],"cohort":[37],"study.":[38],"SETTING:":[39],"Large,":[40],"academic,":[41],"tertiary-care":[42],"hospital.":[43],"PATIENTS:":[44],"One":[45],"hundred":[46],"ninety-one":[47],"adults":[48],"hospitalized":[49],"between":[50,203],"July":[51,55],"1,":[52,56],"2009,":[53],"2012,":[57],"with":[58,94,96,250,262,273,311],"normal":[59],"baseline":[60],"renal":[61],"function":[62],"who":[63,294],"received":[64,84,111,295],"a":[65,85,167,195],"minimum":[66,86,196],"48":[68,88,101],"hours":[69,89,102],"for":[72],"any":[73],"indication":[74],"were":[75],"included":[76],"analysis.":[79],"Of":[80],"these":[81],"patients,":[82],"92":[83,222],"intravenous":[91],"concurrently":[93],"vancomycin,":[95],"being":[98],"initiated":[99],"within":[100,140],"initiation":[105],"(combination":[108],"group);":[109],"99":[110,211],"without":[113],"(vancomycin":[115],"group).":[116],"MEASUREMENTS":[117],"AND":[118],"MAIN":[119],"RESULTS:":[120],"A":[121,177,298],"univariate":[122,234],"analysis":[123],"was":[124,180,248,308],"performed":[125],"assess":[127],"effect":[129],"following":[132],"on":[135],"first":[142],"7":[143],"days":[144],"treatment:":[147],"concomitant":[148,296],"nephrotoxic":[149],"agents,":[150],"advanced":[151],"age,":[152],"steady-state":[153,299],"trough":[155,238,301],"concentration":[156,239,302],"15":[158,219,241,304],"\u03bcg/ml":[159,242,305],"or":[160,175,243,306],"greater,":[161],"elevated":[162],"Charlson":[163],"Comorbidity":[164],"Index,":[165],"total":[168],"daily":[169],"dose":[171],"4":[173],"g":[174],"greater.":[176],"multivariate":[178,259],"model":[179],"constructed":[181],"compare":[183],"primary":[188],"end":[189],"point":[190],"nephrotoxicity,":[192,272],"defined":[193],"as":[194],"1.5-fold":[197],"serum":[200],"creatinine":[201],"concentration,":[202],"groups.":[204],"Nephrotoxicity":[205],"developed":[206],"8":[208],"(8.1%)":[209],"group":[216,227],"(16.3%)":[220],"combination":[226],"(1-sided":[228,279],"\u03c7(2)":[229,280],"test,":[230,281],"p=0.041).":[231],"In":[232,257],"analysis,":[235,260],"only":[236],"greater":[244,307],"(odds":[245],"ratio":[246,276],"3.67)":[247],"associated":[249,310],"developing":[255],"added":[264],"exhibited":[267],"odds":[275],"2.48":[278],"p=0.032).":[282],"CONCLUSION:":[283],"We":[284],"observed":[285],"vancomycin-treated":[292],"piperacillin-tazobactam.":[297],"also":[309],"development":[317],"These":[320],"findings":[321],"should":[322],"be":[323],"confirmed":[324],"larger,":[326],"randomized":[327],"studies.":[328]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005918477","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":27},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":29},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
